Great Point Partners LLC Ardelyx, Inc. Transaction History

Great Point Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.51 - $1.17 $2.43 Million - $5.57 Million	-4,761,905 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.65 - $1.18 $3.1 Million - $5.62 Million	4,761,905 New	4,761,905 $5.1 Million
Q4 2017 Feb 14, 2018	SELL	$4.85 - $7.8 $598,082 - $961,864	-123,316 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.7 $536,424 - $702,901	123,316	123,316 $691,000

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.